Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)
Cardiovascular diseases are one of the main causes of mortality and disability among the population of the member countries of the Eurasian Association of Cardiology, which is directly related to the high prevalence of risk factors for atherosclerosis, among which dyslipidemia plays a leading role. The previous version of the Eurasian Recommendations for the Diagnosis and correction of lipid metabolism disorders for the prevention and treatment of atherosclerosis was presented in 2020. Over the past 5 years, approaches to risk stratification, diagnosis of subclinical atherosclerosis, and correction of dyslipidemia using various classes of lipid-lowering drugs have changed significantly. Among the initial updates, proposals should be highlighted for determining the blood lipid level in each adult or upon reaching the age of 18, using the SCORE and/or SCORE2 scales to stratify cardiovascular risk, and non-invasive imaging techniques to assess subclinical atherosclerosis. In the sections devoted to therapy, fixed combinations of lipid-lowering drugs, inclisiran, and bempedoic acid are presented. The section on the prevalence, significance and approaches to correction of hypertriglyceridemia, as well as the section on extracorporeal hemocorrection, has been expanded. A chapter on lipoprotein(a) is introduced. Sections on correction of dyslipidemia in cerebrovascular diseases, heart transplantation and HIV infection are presented. These recommendations will be useful to the phisicians of all specialties for the effective management of their patients.
Authors
- S. Ya. Eregin
- И Е Чазова (ORCID: https://orcid.org/0000-0002-9822-4357)
- В. В. Кухарчук (ORCID: https://orcid.org/0000-0002-7028-362X)
- В. С. Гуревич (ORCID: https://orcid.org/0000-0002-6815-444X)
- О. Л. Барбараш (ORCID: https://orcid.org/0000-0002-4642-3610)
- А. А. Соколов (ORCID: https://orcid.org/0000-0001-7004-0903)
- А. S. Galyavich (ORCID: https://orcid.org/0000-0002-4510-6197)
- М. И. Воевода (ORCID: https://orcid.org/0000-0001-9425-413X)
- У.В. Чубыкина (ORCID: https://orcid.org/0000-0003-2760-2792)
- V. V. Skibitskiy (ORCID: https://orcid.org/0000-0002-7750-7358)
- G A Konovalov (ORCID: https://orcid.org/0000-0001-6644-3064)
- Т. В. Балахонова (ORCID: https://orcid.org/0000-0002-7273-6979)
- М. Г. Бубнова (ORCID: https://orcid.org/0000-0003-2250-5942)
- Anton A. Raskurazhev (ORCID: https://orcid.org/0000-0003-0522-767X)
- В. А. Корнева (ORCID: https://orcid.org/0000-0003-2231-4695)
- М. В. Ежов (ORCID: https://orcid.org/0000-0002-1518-6552)
- S. S. Yаkushin (ORCID: https://orcid.org/0000-0002-1394-3791)
- M. М. Tanashyan (ORCID: https://orcid.org/0000-0002-5883-8119)
- И. В. Сергиенко (ORCID: https://orcid.org/0000-0003-1534-3965)
- И. И. Шапошник (ORCID: https://orcid.org/0000-0002-7731-7730)
- Н. М. Ахмеджанов (ORCID: https://orcid.org/0000-0003-3417-0895)
- S. Pokrovsky (ORCID: https://orcid.org/0000-0001-5944-6427)
- А. А. Семенкин
- Alexander E. Philippov (ORCID: https://orcid.org/0000-0002-4413-5068)
Institutions
- Kuban State Medical University (RU)
- St Petersburg University (RU)
- Omsk State Medical University (RU)
- Petrozavodsk State University (RU)
- Yaroslavl State Medical Academy (RU)
- Chelyabinsk State Medical Academy (RU)
- Federal Research Center of Fundamental and Translational Medicine (RU)
- Steris (United States) (US)
- Ryazan State Medical University named after Academician I.P. Pavlov (RU)
- National Medical Research Center of Cardiology (RU)
- Research Center of Neurology (RU)
- Kemerovo State University (RU)
Publication Details
- Journal
- Eurasian heart journal
- Published
- 2025-06-02
- DOI
- https://doi.org/10.38109/2225-1685-2025-2-6-34
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- American Heart Association
- Public Health Agency of Canada
- National Heart, Lung, and Blood Institute